ACB (Aurora Cannabis) ROCE %: 4.91% (As of Mar. 2026)


ACB Aurora Cannabis Inc ACB
63 GF Score
Price $2.83
GF Value $4.18
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Aurora Cannabis ROCE %?

Aurora Cannabis ACB -0.70% 63 ROCE % is 4.91% as of Mar. 2026. GuruFocus rates ACB with a GF Score™ of 63/100 and a GF Value™ of $4.18 (Possible Value Trap). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aurora Cannabis's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.91%.

Aurora Cannabis  (NAS:ACB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aurora Cannabis ROCE % Related Terms

Aurora Cannabis ROCE % Historical Data

* Premium members only.

The historical data trend for Aurora Cannabis's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Cannabis ROCE % Chart

Aurora Cannabis Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.67 -92.58 -5.09 4.51 -8.80

Aurora Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.29 -10.15 -27.08 0.33 4.91
ACB
63GF Score
Aurora Cannabis Inc ACB
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Cannabis ROCE % Calculation

Aurora Cannabis's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=-39.88/( ( (593.944 - 77.224) + (438.11 - 48.783) )/ 2 )
=-39.88/( (516.72+389.327)/ 2 )
=-39.88/453.0235
=-8.80 %

Aurora Cannabis's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=20.76/( ( (562.009 - 105.788) + (438.11 - 48.783) )/ 2 )
=20.76/( ( 456.221 + 389.327 )/ 2 )
=20.76/422.774
=4.91 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.91% mean?
Aurora Cannabis (ACB) has a ROCE % of 4.91% as of Mar. 2026.
Is Aurora Cannabis' ROCE % too high?
Aurora Cannabis' current ROCE % is 4.91%. The Drug Manufacturers industry median ROCE % is 7.00. Aurora Cannabis' value of 4.91% is 29.8% below this industry median. Overall, Aurora Cannabis has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' ROCE % compare to ZTS?
Aurora Cannabis' ROCE % of 4.91% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Aurora Cannabis' value of 4.91% is 29.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Cannabis's current ROCE % of 4.91% is 29.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Cannabis's current ROCE % is 4.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.18, compared to a current price of $2.83 — trading 32.3% below its estimated fair value. The current ROCE % is 4.91% and 29.8% below the Drug Manufacturers industry median of 7.00. Aurora Cannabis' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current ROCE % is 4.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Cannabis (ACB) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of $2.83 is trading 32.3% below its estimated GF Value™ of $4.18. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for ACB:

  • ROCE %: 4.91%
  • GF Value™: $4.18 vs. price of $2.83 (32.3% below fair value)
  • GF Score™: 63/100 with 2 warning signs
  • Industry Position: 29.8% below the Drug Manufacturers median

No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
63GF Score

Get the complete analysis for ACB

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.83
Price
$4.18
GF Value